Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cylene begins phase I trial of CX-4945 in multiple myeloma

Oct. 1, 2010

Homopiperazine acethydrazide derivatives patented as oncolytic agents

Sep. 30, 2010

Genta initiates new phase II trial of tesetaxel in advanced bladder cancer

Sep. 30, 2010

Pfizer discontinues phase III Sutent trial in castration-resistant prostate cancer

Sep. 30, 2010

New phase II OGX-427 trial begins in metastatic prostate cancer

Sep. 30, 2010

Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets

Sep. 30, 2010

Pivotal trial data reported on brentuximab vedotin in Hodgkin's lymphoma

Sep. 29, 2010

NCI selects Bexion to collaborate on cancer nanotherapeutic SapC-DOPS

Sep. 29, 2010

Takeda investigators describe new inhibitors of CDC7-related protein kinase

Sep. 28, 2010

AstraZeneca's phase III zibotentan trial in CRPC does not meet primary endpoint

Sep. 28, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...